LD-2 disclosure · 2nd Quarter - Report
INFUSION PROVIDERS ALLIANCE
Client
- Description
- Association representing infusion drug providers.
- Location
- Delaware · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesMedicare/Medicaid
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
LobbyistsJOHN MCMANUS · ms LAWREN D GEER · ALEX WHALEN
Covered position (JOHN MCMANUS): Staff Director, W&M Health Subcommittee. LA, Rep. Bill Thomas.
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Health Issues
Advocating for access to and reimbursement for biosimilars. Issues related to patient access to infusion products for asthma and allergies.
LobbyistsJOHN MCMANUS · ms LAWREN D GEER · ALEX WHALEN
TargetedSENATE · HOUSE OF REPRESENTATIVES